New hope for UTI-prone patients: bacterial lysate aims to slash antibiotic use
NCT ID NCT06588010
First seen Nov 01, 2025 · Last updated May 20, 2026 · Updated 40 times
Summary
This study tests whether OM-89, an extract from E. coli bacteria, can reduce the number of antibiotic treatments needed for urinary tract infections in adults with neurogenic bladder who use catheters. Participants will receive either OM-89 or a placebo for one year. The goal is to see if OM-89 can prevent infections and lower antibiotic use, which is especially important given the high risk of antibiotic-resistant bacteria in this group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEUROGENIC BLADDER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU Dijon Bourgogne
RECRUITINGDijon, 21000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.